COVINGTON, US: Ashland Inc has appointed William G Dempsey, a long-time pharmaceutical industry executive, who currently serves as a director of Landauer Inc (LDR) and Hill-Rom Holdings (HRC) to its board of directors.
Dempsey previously served in various executive positions with Abbott Laboratories from 1982-2007. He also served on the board of Hospira Inc through September 2015 and Nordion Inc through 2014.
Dempsey has previously served as chairman of the International Section of the Pharmaceutical Research and Manufacturers of America (PhRMA) and as chairman of the Accelerating Access Initiative, a cooperative public-private partnership of UNAIDS, the World Bank and six research-based pharmaceutical companies.
He also previously served as member of the Salvation Army Advisory Board in Chicago. Dempsey continues to serve on the board of trustees for the Guadalupe Center in Immokalee, Florida.
"Bill's significant experience within the pharmaceutical industry - a core growth market for Ashland - as well as within international operations makes him an ideal addition to the Ashland board," said William Wulfsohn, Ashland chairman and CEO. "We believe his strategic insights and industry perspective will prove valuable as we position Ashland to be the world's premier speciality chemicals company."
© Worldofchemicals News